The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Cardlytics Inc (NASDAQ: CDLX) closed at $1.88 down -7.84% from its previous closing price of $2.04. In other words, the price has decreased by -$7.84 from its previous closing price. On the day, 0.89 million shares were traded. CDLX stock price reached its highest trading level at $2.07 during the session, while it also had its lowest trading level at $1.87.
Ratios:
For a deeper understanding of Cardlytics Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 96.76. For the most recent quarter (mrq), Quick Ratio is recorded 1.19 and its Current Ratio is at 1.19. In the meantime, Its Debt-to-Equity ratio is 3.44 whereas as Long-Term Debt/Eq ratio is at 2.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on October 11, 2024, initiated with a In-line rating and assigned the stock a target price of $4.
On August 16, 2024, Northland Capital Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $5.
BofA Securities Downgraded its Neutral to Underperform on August 15, 2024, whereas the target price for the stock was revised from $4 to $3.50.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 02 ’25 when Gupta Amit sold 6,725 shares for $1.78 per share. The transaction valued at 11,988 led to the insider holds 378,704 shares of the business.
DeSieno Alexis sold 7,324 shares of CDLX for $13,056 on Jul 02 ’25. The Chief Financial Officer now owns 171,858 shares after completing the transaction at $1.78 per share. On Jul 02 ’25, another insider, Lynton Nicholas Hollmeyer, who serves as the Chief Legal & Privacy Officer of the company, sold 5,271 shares for $1.78 each. As a result, the insider received 9,396 and left with 109,636 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDLX now has a Market Capitalization of 98704512 and an Enterprise Value of 267384496. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.36 while its Price-to-Book (P/B) ratio in mrq is 1.53. Its current Enterprise Value per Revenue stands at 0.981 whereas that against EBITDA is -6.657.
Stock Price History:
The Beta on a monthly basis for CDLX is 1.27, which has changed by -0.7350247 over the last 52 weeks, in comparison to a change of 0.20277917 over the same period for the S&P500. Over the past 52 weeks, CDLX has reached a high of $8.36, while it has fallen to a 52-week low of $1.22. The 50-Day Moving Average of the stock is 0.19%, while the 200-Day Moving Average is calculated to be -30.47%.
Shares Statistics:
For the past three months, CDLX has traded an average of 1.32M shares per day and 2972650 over the past ten days. A total of 52.17M shares are outstanding, with a floating share count of 49.77M. Insiders hold about 5.20% of the company’s shares, while institutions hold 54.95% stake in the company. Shares short for CDLX as of 1752537600 were 6416322 with a Short Ratio of 4.87, compared to 1749772800 on 8016566. Therefore, it implies a Short% of Shares Outstanding of 6416322 and a Short% of Float of 14.280000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
